Metraipolis › archive › dc_c6f4fe648dfd

KIT-Mutant Melanoma: Understanding the Pathway to Personalized Therapy — Europe PMC PMID:41301010

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41301010
DOI: 10.3390/cancers17223644
License (as archived): solo-consultazione
Archived: 2026-11-08T14:53:51.091Z
SHA-256 of the archived text: 70178b999e1af25d4e661bf56ea135a72d73f014fccfe65ce9d21972e1af2e0e
Stable URL of this page: https://metraipolis.com/documento/dc_c6f4fe648dfd

How to cite

KIT-Mutant Melanoma: Understanding the Pathway to Personalized Therapy — Europe PMC PMID:41301010 — Europe PMC (en), https://europepmc.org/article/MED/41301010 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c6f4fe648dfd (Metraipolis archive dc_c6f4fe648dfd, sha256 70178b999e1af25d4e661bf56ea135a72d73f014fccfe65ce9d21972e1af2e0e)

BibTeX

@misc{dcc6f4fe648dfd,
  title = {KIT-Mutant Melanoma: Understanding the Pathway to Personalized Therapy — Europe PMC PMID:41301010},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41301010},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c6f4fe648dfd; sha256 70178b999e1af25d4e661bf56ea135a72d73f014fccfe65ce9d21972e1af2e0e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41301010. Agents can read the archived copy with the MCP tool read_document.